Barrett's Esophagus
Pipeline by Development Stage
Drug Modality Breakdown
On Market (2)
Approved therapies currently available
Competitive Landscape
10 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 17 trials with date data
Clinical Trials (17)
Total enrollment: 8,330 patients across 17 trials
Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
Barrett's Esophagus - 315 - 3 Way Cross Over
Barrett's Esophagus - 315 - 3 Way Cross-Over
YF476 in Barrett's Esophagus
Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
The Captivator EMR Registry
Cytosponge Adequacy Study Evaluation II
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy
A Dose-Optimization Study for the Initial Treatment of Dysplastic Barrett's Esophagus With trūFreeze™ Spray Cryotherapy
Prevalence of Dysplasia of the Gastric Cardia
PillCam® ESO 2 in Esophageal Pathologies
Study of Endoscopic Barrett's Esophagus Diagnosis
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.